ATE420624T1 - Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen - Google Patents

Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Info

Publication number
ATE420624T1
ATE420624T1 AT03809756T AT03809756T ATE420624T1 AT E420624 T1 ATE420624 T1 AT E420624T1 AT 03809756 T AT03809756 T AT 03809756T AT 03809756 T AT03809756 T AT 03809756T AT E420624 T1 ATE420624 T1 AT E420624T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical compositions
eye diseases
nanoparticles
ophthalmic
Prior art date
Application number
AT03809756T
Other languages
English (en)
Inventor
Maria Gasco
Gian Zara
Marco Saettone
Original Assignee
Gasco Maria Rosa
Zara Gian Paolo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gasco Maria Rosa, Zara Gian Paolo filed Critical Gasco Maria Rosa
Application granted granted Critical
Publication of ATE420624T1 publication Critical patent/ATE420624T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03809756T 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen ATE420624T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002323A ITMI20022323A1 (it) 2002-10-31 2002-10-31 Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.

Publications (1)

Publication Number Publication Date
ATE420624T1 true ATE420624T1 (de) 2009-01-15

Family

ID=32211395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03809756T ATE420624T1 (de) 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Country Status (9)

Country Link
US (1) US20060024374A1 (de)
EP (1) EP1567125B1 (de)
CN (1) CN100594888C (de)
AT (1) ATE420624T1 (de)
AU (1) AU2003301747A1 (de)
CA (1) CA2504199C (de)
DE (1) DE60325887D1 (de)
IT (1) ITMI20022323A1 (de)
WO (1) WO2004039351A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012136B2 (en) * 2003-05-20 2011-09-06 Optimyst Systems, Inc. Ophthalmic fluid delivery device and method of operation
EP1624938B1 (de) * 2003-05-20 2011-03-16 James F. Collins Ophthalmisches arzneimittelabgabesystem
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
ITMI20041151A1 (it) * 2004-06-09 2004-09-09 Maria Rosa Gasco Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
EP1674085A1 (de) * 2004-12-22 2006-06-28 Universite Libre De Bruxelles Feste Lipidteilchen als pharmazeutische annehmbare Füllstoffe oder Träger zur Inhalation
WO2007103435A2 (en) * 2006-03-06 2007-09-13 The Regents Of The University Of California Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
WO2009013563A2 (en) * 2006-11-13 2009-01-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases or disorders of the eye
JP2010519203A (ja) * 2007-02-16 2010-06-03 メルク・シャープ・エンド・ドーム・コーポレイション 生物活性分子の活性を強化するための組成物及び方法
US20090061009A1 (en) * 2007-08-29 2009-03-05 Joseph Schwarz Composition and Method of Treatment of Bacterial Infections
AP2895A (en) * 2007-12-24 2014-05-31 Sun Pharma Advanced Res Co Ltd Nanodispersion
US20090212133A1 (en) * 2008-01-25 2009-08-27 Collins Jr James F Ophthalmic fluid delivery device and method of operation
ITMI20090284A1 (it) * 2009-02-26 2010-08-27 Consiglio Nazionale Ricerche Uso di inibitori della serina palmitoiltrasferasi per la prevenzione e il rallentamento delle degenerazioni retiniche ereditarie e relative composizioni
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
US8778364B2 (en) 2009-06-19 2014-07-15 Sun Pharma Advanced Research Company Ltd. Nanodispersion of a drug and process for its preparation
CA2805426C (en) 2010-07-15 2020-03-24 Corinthian Ophthalmic, Inc. Drop generating device
CA2805635A1 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
KR20130051476A (ko) 2010-07-15 2013-05-20 코린시언 아프샐믹 인코포레이티드 안과용 약물 전달
RU2460517C1 (ru) * 2011-07-14 2012-09-10 Федеральное государственное учреждение "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Фармацевтическая композиция для комплексного лечения заболеваний глазной поверхности у больных с первичной открытоугольной глаукомой
US20130172830A1 (en) 2011-12-12 2013-07-04 Corinthian Ophthalmic, Inc. Ejector mechanism, ejector device, and methods of use
WO2014037498A2 (en) 2012-09-07 2014-03-13 Bracco Imaging Spa Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri.
US9511341B2 (en) 2013-08-30 2016-12-06 Sunny Pharmtech Inc. Method for preparing acetazolamide sodium powder
US20170099833A1 (en) * 2014-05-30 2017-04-13 Oms Investments, Inc. Nano-sized water-based dispersion compositions and methods of making thereof
CA2963872C (en) * 2014-10-09 2023-09-12 Distretto Tecnologico Sicilia Micro E Nano Sistemi S.C.A.R.L. Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
US11938056B2 (en) 2017-06-10 2024-03-26 Eyenovia, Inc. Methods and devices for handling a fluid and delivering the fluid to the eye
EP4034645A1 (de) 2019-09-23 2022-08-03 Ecole Polytechnique Federale De Lausanne (Epfl) Behandlung und prävention von altersbedingten erkrankungen und/oder von alterung durch hemmung von sphingolipiden
CA3164288A1 (en) 2019-12-11 2021-06-17 Eyenovia, Inc. Systems and devices for delivering fluids to the eye and methods of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904649A (en) * 1986-05-23 1990-02-27 New England Medical Center Hospitals, Inc. Method and solution for treating glaucoma
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
IT1298575B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
US20030072794A1 (en) * 2000-06-09 2003-04-17 Teni Boulikas Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
US6720008B2 (en) * 2002-01-22 2004-04-13 Pr Pharmaceuticals, Inc. Composition and method for the encapsulation of water-soluble molecules into nanoparticles
US7067479B2 (en) * 2002-09-30 2006-06-27 Bausch & Lomb Inc. Compositions with enhanced antimicrobial efficacy against E. coli

Also Published As

Publication number Publication date
DE60325887D1 (de) 2009-03-05
AU2003301747A1 (en) 2004-05-25
CA2504199C (en) 2011-10-18
US20060024374A1 (en) 2006-02-02
AU2003301747A8 (en) 2004-05-25
CN100594888C (zh) 2010-03-24
CA2504199A1 (en) 2004-05-13
EP1567125A2 (de) 2005-08-31
CN1756529A (zh) 2006-04-05
ITMI20022323A1 (it) 2004-05-01
WO2004039351A2 (en) 2004-05-13
EP1567125B1 (de) 2009-01-14
WO2004039351A3 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
DE60325887D1 (de) Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen
DK1385452T3 (da) Anordning til tilförsel af et ophthalmisk medikament
Yaylali et al. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis
NO20045656L (no) Oftalmologisk anvendelse av roflumilast for behandlingen av oyesykdommer
WO2002041883A3 (en) As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
AR039130A2 (es) Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
CA2508303A1 (en) Drug delivery system using subconjunctival depot
CY1113423T1 (el) Συστημα παροχης φαρμακου για την υποεπιπεφυκοτικη χορηγηση λεπτων κοκκων
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
NO20065904L (no) Terapeutiske forbindelser
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
DE60233898D1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
BR0016402A (pt) Método para aumentar a permeabilidade da pele ou do tecido mucoso a agentes farmaceuticamente ou cosmeticamente ativos administrados por via tópica ou transdérmica
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
CN102066402A (zh) 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物
BR0209063A (pt) Medicamentos e kits de uso medicinal
WO2007022541A3 (en) Method of treating dry eye disease with non-drying antihistamines
SE9301877D0 (sv) In situ gel for therapeutic use
ES2197781A1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
Abdelaziz et al. The potential of active metabolites of antihistamines in the management of allergic disease.
NO20013605L (no) Preparat for vorter
CA2474703A1 (en) Therapeutic agent of glaucoma comprising bunazosin and prostaglandins
JPH0977656A (ja) 点眼用エアゾル組成物

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties